SecBot SecBot
PRESS-RELEASE ·Filed Oct 15, 2026

MED

Medifast
NEUTRAL
Impact 2/10
Horizonweeks Processed11d 5h ago WireGlobeNewswire
Press release · Announcement
Actionable Insight • Neutral

This is a brand-awareness press release with no hard financial data. Monitor upcoming quarterly earnings for any impact from Trilivy's market positioning. No immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d
MED ▲ +0.91% at T+5d
NEUTRAL call +0.91% · α vs SPY +1.93% · entry $12.06 → $12.17
Next anchor: T+20d in 17d
Latest observation: T+6 -0.69% FF3 residual α
Entry = T+0 close
Oct 15, 2026
via day close
T+1d
-1.49%
call -1.49% · α -0.39%
$11.88
settled 10d ago
T+5d
+0.91%
call +0.91% · α +1.93%
$12.17
settled 4d ago
T+20d
Pending
in 17d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Medifast issued a press release debunking menopause weight gain myths and promoting its Trilivy metabolic health system, citing clinical data showing 14% visceral fat reduction and 97-98% lean mass retention on the Reset 5 & 1 Plan. The release is purely marketing content with no financial data, guidance, or material corporate events.

Key Facts

  • Press release is a marketing piece promoting Trilivy metabolic health system for menopause/perimenopause
  • No financial results, guidance, or material corporate events disclosed
  • Clinical data cited: 14% visceral fat reduction and 97-98% lean mass retention at 16 weeks on Reset 5 & 1 Plan
  • No revenue, EPS, or other financial metrics reported

Financial Impact

No financial impact disclosed

Risk Factors

  • No financial data to assess business performance
  • Marketing content does not indicate revenue trends or guidance changes

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3381493
15 reports for MED
Performance horizon
100% Hit rate @ T+5 4 of 4 directional calls Went positive at some point 4 of 4 best @ T+60▲ +23.89%May 4, 2026
Filters
Rows
Reports for MED — sortable, filterable
TypeNow
Oct 26, 2026
today
8-K
NEUTRAL ★ 6/10
—awaiting T+5——
Oct 15, 2026
11d ago
Press Release
NEUTRAL ★ 2/10
$12.06 $12.17▲ +0.91%▲ +1.93%$12.25 (+1.58%)
Oct 6, 2026
20d ago
Press Release
NEUTRAL ★ 2/10
$11.51 $11.67▲ +1.39%▲ +1.53%$12.25 (+6.43%)
Oct 1, 2026
25d ago
Press Release
NEUTRAL ★ 2/10
$11.43 $11.43· 0.00%▼ −1.30%$12.25 (+7.17%)
Aug 28, 2026
8w ago
Insider Buy
BULLISH ★ 6/10
$12.18 $12.63▲ +3.69%▲ +3.59%$12.25 (+0.57%)
Aug 26, 2026
8w ago
Insider Buy
BULLISH ★ 6/10
$12.22 $12.67▲ +3.68%▲ +3.80%$12.25 (+0.25%)
Aug 21, 2026
9w ago
Insider Buy
BULLISH ★ 6/10
$11.95 $12.18▲ +1.92%▲ +1.45%$12.25 (+2.51%)
Jul 17, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$10.26 $9.45▼ −7.89%▼ −7.21%$12.25 (+19.40%)
Jun 1, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$12.70 $12.10▼ −4.72%▼ −1.97%$12.25 (−3.54%)
May 26, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$12.72 $12.36▼ −2.83%▼ −4.04%$12.25 (−3.69%)
Showing 10 of 15

US Market Status

Market Open — Closes in 3h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 15, 2026